Courage Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-16,100
Closed -$4.32M 36
2020
Q3
$4.32M Buy
16,100
+11,100
+222% +$2.99M 4.83% 7
2020
Q2
$1.31M Sell
5,000
-11,500
-70% -$3.07M 2.42% 15
2020
Q1
$3.75M Buy
+16,500
New +$4.5M 8.46% 5
2019
Q4
Sell
-7,500
Closed -$1.8M 16
2019
Q3
$1.8M Hold
7,500
2.89% 6
2019
Q2
$2.12M Buy
+7,500
New +$2.05M 3.59% 6

Other funds holding ELV

Courage Capital Management's ELV Position: Q4 2020 in Review

Courage Capital Management sold out of Elevance Health (ELV) in Q4 2020, closing a stake of 16,100 shares — an estimated $4.32M sold.

Courage Capital Management first reported a position in ELV in Q2 2019 and held it in 5 quarters. The position peaked at $4.32M in Q3 2020. 1,170 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

  • Courage Capital Management reported no remaining Elevance Health position as of Q4 2020 after selling out during the quarter.
  • Courage Capital Management sold 16,100 Elevance Health shares in Q4 2020, an estimated $4.32M.
  • Courage Capital Management first reported a position in Elevance Health in Q2 2019 and held it in 5 quarters.
  • Courage Capital Management's Elevance Health position peaked at $4.32M in Q3 2020.
  • 1,170 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on Courage Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.